Peter Attia· MD
if it's not we can use in individual patients these Oddball biomarkers that is what I think is part of medicine 3.0 where we maybe use a little smarter uh knowledge to try and do a better job
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if it's not we can use in individual patients these Oddball biomarkers that is what I think is part of medicine 3.0 where we maybe use a little smarter uh knowledge to try and do a better job
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if it's not we can use in individual patients these Oddball biomarkers that is what I think is part of medicine 3.0 where we maybe use a little smarter uh knowledge to try and do a better job